[Helicobacter pylori infection in patients with liver cirrhosis: diagnostics and problems of therapy].
Iakovenko
A V
AV
Grigor'ev
P Ia
PIa
Obukhovskiĭ
B I
BI
Mel'nikova
S V
SV
Guseĭnova
L A
LA
Mardar'eva
S V
SV
Agafonova
N A
NA
Prianishnikova
A S
AS
Soluianova
I P
IP
Gioeva
I Z
IZ
Iakovenko
E P
EP
D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D016480:Helicobacter pylori / Q000187:drug effects / Q000302:isolation & purification; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications* / Q000453:epidemiology; D008297:Male; D013272:Stomach Diseases / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology
D000890:Anti-Infective Agents; D005765:Gastrointestinal Agents